来自皮肤病学大师班2024年会议:牛皮治疗的最新情况
Beth Childs1, Sarah Romanelli2, Joseph F Merola1
1Ms. Childs and Dr. Merola are with the Department of Dermatology and Department of Medicine, Division of Rheumatology at UT Southwestern Medical Center in Dallas, Texas.
The Journal of clinical and aesthetic dermatology
|March 13, 2025
概括
牛皮的治疗正在推进,新的生物药物向IL-17和IL-23,以及口服药物,如deucravacitinib. 医疗保险覆盖范围正在扩大,生物药物可以预防牛皮关节炎的发病.
科学领域:
- 皮肤病学 皮肤病学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 牛皮 (PsO) 是一种慢性炎症性皮肤疾病,影响生活质量.
- 对于PsO的治疗环境正在迅速发展,有新的治疗选择.
- 牛皮关节炎 (PsA) 是一种常见的并发症,显著降低了患者的幸福感.
研究的目的:
- 为了概述最近在牛皮治疗方面的进展.
- 以突出显示生物制剂,医疗保险覆盖,PsA过渡和口服疗法的最新情况.
- 为了指导临床医生管理患有PsO治疗选择的患者.
主要方法:
- 对针对IL-17,IL-23和IL-36通路的新兴生物疗法的审查.
- 对TNF抑制剂的可互换生物类似药的讨论.
- 对口服药物的分析,包括TYK2抑制剂和IL-23受体对抗剂.
- 对生物制品的医疗保险覆盖范围变化的审查.
- 考虑生物制剂在预防PsA发病中的作用.
主要成果:
- 扩大生物选择可以在多个领域改善疾病控制.
- 可互换的生物仿制药改善了获取并降低了成本.
- 斯佩索利马布在一般性性牛皮病中显示出有效性.
- 医疗保险覆盖范围的扩大改善了特定患者群体的治疗机会.
- 生物药物在预防PsO患者的PsA发展方面表现出潜力.
- 像deucravacitinib这样的口服疗法提供了有效和安全的治疗选择.
结论:
- 不断发展的治疗环境使得 psoriasis 患者能够获得更加个性化的护理.
- 新的生物和口服药物,以及改善的获取,正在改变PsO的管理.
- 了解这些进展对于优化患者的治疗结果和生活质量至关重要.
相关概念视频
01:22iPS Cell Differentiation
2.6K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.6K
01:21EPS and iPS Cells in Disease Research
2.7K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.7K
01:19Clinical Applications of Epidermal Stem Cells
2.7K
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
2.7K
01:12Renewal of Skin Epidermal Stem Cells
2.4K
The skin is divided into epidermis, dermis, and hypodermis, the skin's outermost, middle, and inner layers. The human epidermal layer regularly undergoes renewal, where old, dead cells are replaced by new cells. Epidermal stem cells or EpiSCs divide and differentiate to restore the lost cells. For the renewal process, some EpiSCs continuously self-renew. In contrast, few others differentiate into transit-amplifying cells, which later form prickle or spinous cells, followed by granular...
2.4K
01:30Skin Cancer
3.0K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
3.0K